227 related articles for article (PubMed ID: 25196808)
1. Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.
Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H
J Thromb Haemost; 2014 Nov; 12(11):1801-9. PubMed ID: 25196808
[TBL] [Abstract][Full Text] [Related]
2. Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
Ramirez GA; Mackie I; Nallamilli S; Pires T; Moll R; Pericleous C; Isenberg DA; Cohen H; Efthymiou M
Rheumatology (Oxford); 2021 Mar; 60(3):1376-1386. PubMed ID: 32964932
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants.
Liestøl S; Sandset PM; Mowinckel MC; Wisløff F
J Thromb Haemost; 2007 Nov; 5(11):2204-10. PubMed ID: 17958739
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.
Efthymiou M; Arachchillage DRJ; Lane PJ; O'Keeffe AG; McDonnell T; Cohen H; Mackie IJ
Thromb Res; 2018 Oct; 170():60-68. PubMed ID: 30121005
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
Arachchillage DR; Mackie IJ; Efthymiou M; Chitolie A; Hunt BJ; Isenberg DA; Khamashta M; Machin SJ; Cohen H
J Thromb Haemost; 2016 Nov; 14(11):2177-2186. PubMed ID: 27541499
[TBL] [Abstract][Full Text] [Related]
7. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
Kopytek M; Natorska J; Undas A
Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
9. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
[TBL] [Abstract][Full Text] [Related]
10. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay.
Gardiner C; Cohen H; Jenkins A; Machin SJ; Mackie IJ
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):477-83. PubMed ID: 16905952
[TBL] [Abstract][Full Text] [Related]
11. Use of direct oral anticoagulants in antiphospholipid syndrome.
Cohen H; Efthymiou M; Isenberg DA
J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.
Pleguezuelo DE; Díaz-Simón R; Cabrera-Marante O; Lalueza A; Paz-Artal E; Lumbreras C; Serrano Hernández A
Front Immunol; 2021; 12():667515. PubMed ID: 33912194
[TBL] [Abstract][Full Text] [Related]
13. Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome.
Ząbczyk M; Celińska-Löwenhoff M; Plens K; Iwaniec T; Musiał J; Undas A
J Thromb Haemost; 2019 Oct; 17(10):1746-1755. PubMed ID: 31220407
[TBL] [Abstract][Full Text] [Related]
14. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Acquired Activated Protein C Resistance, Using the CAT and ST-Genesia
Efthymiou M; Lane PJ; Isenberg D; Cohen H; Mackie IJ
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011808
[TBL] [Abstract][Full Text] [Related]
17. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome - an update.
Linnemann B
Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.
Pengo V; Ruffatti A; Legnani C; Gresele P; Barcellona D; Erba N; Testa S; Marongiu F; Bison E; Denas G; Banzato A; Padayattil Jose S; Iliceto S
J Thromb Haemost; 2010 Feb; 8(2):237-42. PubMed ID: 19874470
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome.
Efthymiou M; Lawrie AS; Mackie I; Arachchillage D; Lane PJ; Machin S; Cohen H
Thromb Res; 2015 Jun; 135(6):1191-7. PubMed ID: 25895847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
